Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Radiotherapy‐Induced Cleavage of Quaternary Ammonium Groups Activates Prodrugs in Tumors
Zhibin Guo, Hanyu Hong, Yuedan Zheng, et al.
Angewandte Chemie International Edition (2022) Vol. 61, Iss. 34
Closed Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Stimuli-activatable nanomedicine meets cancer theranostics
Haonan Li, Feng Yue, Qiang Luo, et al.
Theranostics (2023) Vol. 13, Iss. 15, pp. 5386-5417
Open Access | Times Cited: 135
Recent Progress of Supramolecular Chemotherapy Based on Host–Guest Interactions
Miaomiao Yan, Sha Wu, Yuhao Wang, et al.
Advanced Materials (2023) Vol. 36, Iss. 21
Closed Access | Times Cited: 78
Radiotherapy-Triggered Proteolysis Targeting Chimera Prodrug Activation in Tumors
Chunrong Yang, Yuchen Yang, Yujie Li, et al.
Journal of the American Chemical Society (2022) Vol. 145, Iss. 1, pp. 385-391
Closed Access | Times Cited: 74
Nanoscale Metal–Organic Framework with an X-ray Triggerable Prodrug for Synergistic Radiotherapy and Chemotherapy
Ziwan Xu, Wenyao Zhen, Caroline McCleary, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 34, pp. 18698-18704
Open Access | Times Cited: 41
Radiotherapy activates picolinium prodrugs in tumours
Qunfeng Fu, 知子 谷, Siyong Shen, et al.
Nature Chemistry (2024) Vol. 16, Iss. 8, pp. 1348-1356
Closed Access | Times Cited: 18
Bioorthogonal chemistry for prodrug activation in vivo
Qunfeng Fu, Siyong Shen, Pengwei Sun, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 22, pp. 7737-7772
Closed Access | Times Cited: 35
Click-Reaction-Mediated Chemotherapy and Photothermal Therapy Synergistically Inhibit Breast Cancer in Mice
Guiquan Zhang, Xuemei Chen, Xu Chen, et al.
ACS Nano (2023) Vol. 17, Iss. 15, pp. 14800-14813
Closed Access | Times Cited: 28
Stimuli-Responsive Polymers at the Interface with Biology
Nathan R. B. Boase, Elizabeth R. Gillies, Rubayn Goh, et al.
Biomacromolecules (2024) Vol. 25, Iss. 9, pp. 5417-5436
Closed Access | Times Cited: 7
Radiotherapy-triggered reduction of platinum-based chemotherapeutic prodrugs in tumours
Qunfeng Fu, Shuren Zhang, Siyong Shen, et al.
Nature Biomedical Engineering (2024) Vol. 8, Iss. 11, pp. 1425-1435
Closed Access | Times Cited: 6
A cuproptosis nanocapsule for cancer radiotherapy
You Liao, Dongmei Wang, Chenglu Gu, et al.
Nature Nanotechnology (2024)
Closed Access | Times Cited: 6
X‐ray controlled release strategy in cancer therapy
Yiling Ruan, Hongxiang Huang, Huihui Liu, et al.
BMEMat (2025)
Open Access
X‐Ray‐Induced Drug Release for Cancer Therapy
Hui Liu, Jun Zhao, Yufei Xue, et al.
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 39
Open Access | Times Cited: 16
Gold Nanocluster: A Photoelectric Converter for X‐Ray‐Activated Chemotherapy
Fangman Chen, Feixia Ruan, Xiaochun Xie, et al.
Advanced Materials (2024)
Closed Access | Times Cited: 4
X-ray-responsive prodrugs and polymeric nanocarriers for multimodal cancer therapy
Yufei Cao, Jiale Si, Moujiang Zheng, et al.
Chemical Communications (2023) Vol. 59, Iss. 54, pp. 8323-8331
Closed Access | Times Cited: 12
An Activatable Prodrug Nanosystem for Ultrasound‐Driven Multimodal Tumor Therapy and Metastasis Inhibition
Jiazhu Zheng, Haoying Ge, Danhong Zhou, et al.
Advanced Materials (2023) Vol. 35, Iss. 47
Closed Access | Times Cited: 11
Extended Pharmacokinetics Improve Site-Specific Prodrug Activation Using Radiation
Jeremy M. Quintana, Mikyung Kang, Hui-Yu Hu, et al.
ACS Central Science (2024) Vol. 10, Iss. 7, pp. 1371-1382
Open Access | Times Cited: 3
Conditional PROTAC: Recent Strategies for Modulating Targeted Protein Degradation
Junhyeong Yim, Jun‐Young Park, G. H. Kim, et al.
ChemMedChem (2024) Vol. 19, Iss. 22
Closed Access | Times Cited: 3
Radiocatalytic synthesis of acetic acid from CH4 and CO2
Bo‐Shuai Mu, Yugang Zhang, Mi Peng, et al.
Angewandte Chemie International Edition (2024) Vol. 63, Iss. 44
Closed Access | Times Cited: 3
NIR-II Light Leveraged Dual Drug Synthesis for Orthotopic Combination Therapy
Huisi Zhao, Zhengwei Liu, Yue Wei, et al.
ACS Nano (2022) Vol. 16, Iss. 12, pp. 20353-20363
Closed Access | Times Cited: 20
Radiopharmaceuticals heat anti-tumor immunity
Qi Sun, Jiyuan Li, Zexuan Ding, et al.
Theranostics (2023) Vol. 13, Iss. 2, pp. 767-786
Open Access | Times Cited: 10
Bioorthogonal Bond Cleavage Chemistry for On-demand Prodrug Activation: Opportunities and Challenges
Qingqiang Min, Xingyue Ji
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 24, pp. 16546-16567
Closed Access | Times Cited: 10
Locally unlocks prodrugs by radiopharmaceutical in tumor for cancer therapy
Changlun Wang, Mengxin Xu, Zihang Zhang, et al.
Science Bulletin (2024) Vol. 69, Iss. 17, pp. 2745-2755
Closed Access | Times Cited: 3
Progress of proteolysis-targeting chimeras (PROTACs) delivery system in tumor treatment
Lianlian Fan, Weifang Tong, Anhui Wei, et al.
International Journal of Biological Macromolecules (2024) Vol. 275, pp. 133680-133680
Open Access | Times Cited: 2
Targeted Delivery of Quinoxaline-Based Semiconducting Polymers for Tumor Photothermal Therapy
Peiling Chen, Xiaoying Wang, Chunguang Zhu, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 29, pp. 38377-38386
Closed Access | Times Cited: 2
Plant-derived nanovesicles as an emerging platform for cancer therapy
Hanzhe Liu, Guo‐Feng Luo, Z. J. Shang
Acta Pharmaceutica Sinica B (2023) Vol. 14, Iss. 1, pp. 133-154
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top